GALT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Galectin Therapeutics Inc

NASDAQ | GALT

5.05

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$332.47M

Market Cap

-

P/E Ratio

-0.64

EPS

$6.55

52 Week High

$0.72

52 Week Low

HEALTHCARE

Sector

GALT Chart

Recent Chart
Price Action

GALT Technicals

Tags:

GALT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$37K
Total Revenue $0
Cost Of Revenue $37K
Costof Goods And Services Sold $37K
Operating Income -$42M
Selling General And Administrative $5.9M
Research And Development $37M
Operating Expenses $42M
Investment Income Net -
Net Interest Income -$5.2M
Interest Income $338K
Interest Expense $5.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $37K
Income Before Tax -$47M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$47M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$47M

Revenue & Profitability

Earnings Performance

GALT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $17M
Total Current Assets $17M
Cash And Cash Equivalents At Carrying Value $15M
Cash And Short Term Investments $15M
Inventory -
Current Net Receivables -
Total Non Current Assets $243K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2.1M
Other Non Current Assets -
Total Liabilities $121M
Total Current Liabilities $35M
Current Accounts Payable $5.7M
Deferred Revenue -
Current Debt -
Short Term Debt $21M
Total Non Current Liabilities $85M
Capital Lease Obligations $19K
Long Term Debt $85M
Current Long Term Debt $21M
Long Term Debt Noncurrent -
Short Long Term Debt Total $106M
Other Current Liabilities $8.6M
Other Non Current Liabilities -
Total Shareholder Equity -$103M
Treasury Stock -
Retained Earnings -$402M
Common Stock $62K
Common Stock Shares Outstanding $62M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$42M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $37K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $31M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $91K
Dividend Payout Common Stock $91K
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $845K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$47M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$37K
Total Revenue $0
Cost Of Revenue $37K
Costof Goods And Services Sold $37K
Operating Income -$42M
Selling General And Administrative $5.9M
Research And Development $37M
Operating Expenses $42M
Investment Income Net -
Net Interest Income -$5.2M
Interest Income $338K
Interest Expense $5.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $37K
Income Before Tax -$47M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$47M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$47M

GALT News

GALT Profile

Galectin Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Galectin Therapeutics Inc. (GALT) is a clinical-stage biopharmaceutical company based in Norcross, Georgia, specializing in the discovery and development of innovative therapies targeting fibrotic diseases, cancer, and other severe medical conditions. The company's proprietary technology focuses on galectin proteins, which play critical roles in disease progression and tissue inflammation, positioning Galectin Therapeutics to address significant unmet medical needs. With a robust pipeline and strategic research initiatives, GALT aims to advance its therapeutic candidates towards FDA approval, thereby enhancing treatment options for patients confronting challenging health issues.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.12%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
INTC
+4.26%
$37.15
WHWK
+24.28%
$2.61
KVUE
-13.34%
$14.09
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
GDXD
-10.20%
$0.60
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
QBTS
-9.62%
$40.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
SNAP
-1.83%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
JBLU
-3.63%
$4.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
WULF
-9.53%
$13.99
JOBY
-8.66%
$16.07
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
+1.07%
$0.34
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
IVF
+85.67%
$1.40
BITF
-18.39%
$5.28
CGBS
-39.47%
$0.03
COOT
+173.57%
$2.64
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
ADAP
+6.57%
$0.19
BYND
-22.39%
$0.52
YDKG
-54.14%
$0.08
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
LAES
-2.09%
$7.49
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.12%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
INTC
+4.26%
$37.15
WHWK
+24.28%
$2.61
KVUE
-13.34%
$14.09
ACHR
-8.90%
$11.87
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
DFLI
-32.48%
$1.33
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
CAN
-14.28%
$1.68
AAL
-4.88%
$11.89
MARA
-11.27%
$20.26
GDXD
-10.20%
$0.60
AMD
-1.33%
$235.40
SOFI
-6.13%
$26.31
BTBT
-9.11%
$3.69
GNPX
-43.39%
$0.47
QBTS
-9.62%
$40.47
BTG
+3.96%
$5.89
FEMY
+33.89%
$0.73
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-6.14%
$0.36
LGCB
+19.39%
$1.97
ABAT
-21.00%
$8.94
NAK
-4.34%
$2.64
SNAP
-1.83%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
RF
-5.98%
$23.26
RGTZ
+30.51%
$11.35
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
UUUU
-12.80%
$21.79
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
IREN
-8.94%
$61.89
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
JBLU
-3.63%
$4.76
WTO
-88.87%
$0.13
CLSK
-13.92%
$19.97
SMR
-10.87%
$47.62
T
+0.46%
$26.19
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
WULF
-9.53%
$13.99
JOBY
-8.66%
$16.07
BAC
-4.03%
$50.17
MU
+4.60%
$200.77
IONQ
-9.33%
$65.65
APLD
-1.69%
$37.11
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
CLF
-0.07%
$13.95
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-4.90%
$51.16
KDLY
+1.29%
$0.79
SLNH
-1.39%
$4.23
AMC
-2.12%
$2.76
AMZN
-0.81%
$213.82
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.